Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sherven Sharma

Showing results (21-30 of 103) with videos related to

Pageof 11
Sort By:
Biochemical and Biophysical Research Communications|July 31, 2012
Bmi-1 confers adaptive radioresistance to KYSE-150R esophageal carcinoma cellsGuanyu Wang, Luying Liu, Sherven Sharma, et al.
Cancer Research|February 20, 2003
Abnormal interleukin 10Ralpha expression contributes to the maintenance of elevated cyclooxygenase-2 in non-small cell lung cancer cellsNathalie Heuze-Vourc'h, Li Zhu, Kostyantyn Krysan, et al.
Vaccines|November 10, 2020
Immune Checkpoint Blockade Enhances Immune Activity of Therapeutic Lung Cancer VaccinePournima Kadam, Ram P Singh, Michael Davoodi, et al.
Oral Oncology|August 27, 2015
p53 modulates NF-κB mediated epithelial-to-mesenchymal transition in head and neck squamous cell carcinomaYuan Lin, Jon Mallen-St Clair, Jie Luo, et al.
Molecular Pharmacology|April 7, 2007
Pioglitazone and rosiglitazone decrease prostaglandin E2 in non-small-cell lung cancer cells by up-regulating 15-hydroxyprostaglandin dehydrogenaseSaswati Hazra, Raj K Batra, Hsin H Tai, et al.
Cancer Research|July 19, 2005
Prostaglandin E2 activates mitogen-activated protein kinase/Erk pathway signaling and cell proliferation in non-small cell lung cancer cells in an epidermal growth factor receptor-independent mannerKostyantyn Krysan, Karen L Reckamp, Harnisha Dalwadi, et al.
Cancer Research|February 5, 2003
Non-small cell lung cancer-derived soluble mediators enhance apoptosis in activated T lymphocytes through an I kappa B kinase-dependent mechanismRaj K Batra, Ying Lin, Sherven Sharma, et al.
Journal of Neuroimmunology|January 27, 2004
Cocaine modulates cytokine and enhances tumor growth through sigma receptorsBrian Gardner, Li X Zhu, Michael D Roth, et al.
Critical Reviews in Oncology/Hematology|February 29, 2008
Inflammation in lung carcinogenesis: new targets for lung cancer chemoprevention and treatmentJay M Lee, Jane Yanagawa, Katherine A Peebles, et al.
Plos One|August 1, 2012
PAK1 kinase promotes cell motility and invasiveness through CRK-II serine phosphorylation in non-small cell lung cancer cellsMatthew Rettig, Kenny Trinidad, G Pezeshkpour, et al.
Pageof 11

Showing results (21-30 of 103) with videos related to

Sort By:
Pageof 11
Biochemical and Biophysical Research Communications|July 31, 2012
Bmi-1 confers adaptive radioresistance to KYSE-150R esophageal carcinoma cellsGuanyu Wang, Luying Liu, Sherven Sharma, et al.
Cancer Research|February 20, 2003
Abnormal interleukin 10Ralpha expression contributes to the maintenance of elevated cyclooxygenase-2 in non-small cell lung cancer cellsNathalie Heuze-Vourc'h, Li Zhu, Kostyantyn Krysan, et al.
Vaccines|November 10, 2020
Immune Checkpoint Blockade Enhances Immune Activity of Therapeutic Lung Cancer VaccinePournima Kadam, Ram P Singh, Michael Davoodi, et al.
Oral Oncology|August 27, 2015
p53 modulates NF-κB mediated epithelial-to-mesenchymal transition in head and neck squamous cell carcinomaYuan Lin, Jon Mallen-St Clair, Jie Luo, et al.
Molecular Pharmacology|April 7, 2007
Pioglitazone and rosiglitazone decrease prostaglandin E2 in non-small-cell lung cancer cells by up-regulating 15-hydroxyprostaglandin dehydrogenaseSaswati Hazra, Raj K Batra, Hsin H Tai, et al.
Cancer Research|July 19, 2005
Prostaglandin E2 activates mitogen-activated protein kinase/Erk pathway signaling and cell proliferation in non-small cell lung cancer cells in an epidermal growth factor receptor-independent mannerKostyantyn Krysan, Karen L Reckamp, Harnisha Dalwadi, et al.
Cancer Research|February 5, 2003
Non-small cell lung cancer-derived soluble mediators enhance apoptosis in activated T lymphocytes through an I kappa B kinase-dependent mechanismRaj K Batra, Ying Lin, Sherven Sharma, et al.
Journal of Neuroimmunology|January 27, 2004
Cocaine modulates cytokine and enhances tumor growth through sigma receptorsBrian Gardner, Li X Zhu, Michael D Roth, et al.
Critical Reviews in Oncology/Hematology|February 29, 2008
Inflammation in lung carcinogenesis: new targets for lung cancer chemoprevention and treatmentJay M Lee, Jane Yanagawa, Katherine A Peebles, et al.
Plos One|August 1, 2012
PAK1 kinase promotes cell motility and invasiveness through CRK-II serine phosphorylation in non-small cell lung cancer cellsMatthew Rettig, Kenny Trinidad, G Pezeshkpour, et al.
Pageof 11